Edinburgh tech spinout aims to reduce analysis time for genetic data
Scientists at the University of Edinburgh have launched a spinout company that aims to revolutionise the handling of data by drastically reducing the time it takes to analyse millions of genetic records.
Omecu Ltd promises wide-ranging benefits in drug discovery and personalised medicine, while improving patient data security.
The company draws on three years of research led by Dr Oriol Canela-Xandri at the MRC Human Genetics Unit, within the University of Edinburgh’s Institute of Genetics and Cancer, and Dr Konrad Rawlik at the University’s Roslin Institute.
It has been launched with the support of Edinburgh Innovations, the university’s commercialisation service.
It is estimated that global human genomic data is doubling in size every seven months and may soon exceed other big data generators such as astronomy and the internet.
Genomics is the study of all of a person’s genes (the genome), including interactions of those genes with each other and with the person’s environment.
Although this data has the potential to “revolutionise medicine” and lead to new therapeutics and diagnostics, experts say these benefits rely on the ability to unlock clinically actionable knowledge from the data.
The obstacles to accessing such data can prevent valuable information being extracted, by making the process costly and time-consuming.
The Omecu team has developed a computation engine and web platform that will transform how genomic data is securely accessed and efficiently analysed.
They have been supported by Edinburgh Innovations since 2019. They participated in the Innovation to Commercialisation of University Research (ICURe) SETSquared programme in 2020 – a three to four month customer discovery programme designed using lean start-up methodology tools, and received funding from Medical Research Council grants and the university’s Data-Driven Entrepreneurship Seed Fund and Fast Track Mentor initiatives, supported by the Scottish Funding Council.
Omecu is co-founded by Dr Canela-Xandri and Dr Rawlik alongside chief executive Les Gaw, an experienced entrepreneur, investor and adviser to early-stage technology companies, who was introduced to the research team by Edinburgh Innovations.
They have recently been awarded £288,000 from Innovate UK, which will allow Omecu to refine its prototype and progress commercial engagement.
Dr Canela-Xandri, who is a chancellor’s fellow at the university, said: “Our ambition is to create a paradigm shift where disease experts without a computer science background are able to easily query fragmented data sets, while cutting costs and without requiring the data-holding organisation to expose the data itself.“Our recent funding awards mean we can now accelerate the development of our prototype and move towards a commercial product.”
Dr George Baxter, chief executive of Edinburgh Innovations, said: “Genomic data holds great promise for humanity, and the Omecu team have found a way to make it far easier for clinicians to make use of that data. We’re extremely proud to help researchers to launch a company with such potential.”
Professor Wendy Bickmore, director of the MRC Human Genetics Unit at the University of Edinburgh, added: “Having a rapid way to extract useful knowledge from large genomic datasets will accelerate new discoveries and new treatments for human disease.”
The pandemic has taught me how to share more – and I feel a better leader for it
As a young professional starting out in the tech sector 30 years ago, I thrived on the fast pace,constant change and demanding workload. I lived in London, Singapore and Australia…
We need to shout about our successes. Liz Fletcher on celebrating women in biotech
Throughout my career in biotechnology and life sciences, I have seen many women leading ground-breaking research studies in their fields of expertise. Yet, and I include myself in this, we…
Getting the best out of patient data is key to unlocking future health benefits in Scotland
It is important that clinicians’ voices are heard in the consultation around Scotland’s new health and care data strategy, which closes this week (12 August). Busy GPs like myself are the trusted…
How motherhood helped me be a better leader
Consider this an open letter to anyone I have worked with before I became a mother and before I fully understood how being a parent is actually a prized asset…
‘We cannot achieve our goals without entrepreneurs’ – Kate Forbes on vision for new ‘tech scaler’ network
From the very start of my ministerial career, I have had responsibility for the Scottish tech sector – and I can still say what I have said from the start,…
Finding a role in cyber was ‘tough’ for Cheryl Torano. Now she’s determined to help other women join an under-represented industry
When I decided to upskill to change careers at the age of 30 and dive into the digital world, I knew I would be starting out at the bottom of…
Why innovation and marketing are the perfect partners to make changes that matter￼
With the rapid evolution of traditional marketing and the appearance of digital marketing, technology and innovation has become part of any marketer’s life without the need of working for a…
Transitioning to a four-day week – CEO’s vow to strike a healthier balance in the workplace
I came to Scotland nearly 20 years ago from Ireland, with no contacts but a lot of determination. While Ireland will always be my home, Scotland has given me amazing…